Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SAMD9 |
| Upstream (Parents) |
|---|
| (<<) HERC6 → SAMD9 |
| (<<) IFI44L → SAMD9 |
| (<<) IFI44 → SAMD9 |
| (<<) DDX60 → SAMD9 |
| (<<) IFI16 → SAMD9 |
| Downstream (Children) |
|---|
| SAMD9 → CCT8 (>>) |
| SAMD9 → TTC18 (>>) |
| SAMD9 → HERC6 (>>) |
| SAMD9 → SPRR1A (>>) |
| SAMD9 → SPRR1B (>>) |
| SAMD9 → GPR87 (>>) |
| SAMD9 → ZC3H15 (>>) |
| SAMD9 → STS (>>) |
| SAMD9 → DHRS9 (>>) |
| SAMD9 → RGS17 (>>) |
| SAMD9 → RAPGEF1 (>>) |
| SAMD9 → GABRD (>>) |
| SAMD9 → CNPY4 (>>) |
| SAMD9 → BIRC3 (>>) |
| SAMD9 → FAM153C///FAM153A///FAM153B (>>) |
| SAMD9 → ST6GALNAC2 (>>) |
| SAMD9 → OAS1 (>>) |
